Healthcare >> CEO Interviews >> July 13, 2009

Stanislaw R. Burzynski – Burzynski Research Institute (bzyr)

STANISLAW R. BURZYNSKI, M.D., Ph.D., is the physician and biochemist-researcher who pioneered the development and use of biologically active peptides in diagnosing, preventing and treating cancer. Dr. Burzynski graduated from the Medical Academy in Lublin, Poland, in 1967 with a M.D. degree with distinction, and received his Ph.D the following year. In 1977 Dr. Burzynski founded his clinic in Houston where he's since treated over 8,000 patients. He is also the president of the Burzynski Research Institute, where he continues to pursue scientific research on Antineoplastons. Dr. Burzynski is the author and co- author ofover 250 scientific publications and presentations. Currently,he holds 212 patents registered in 35 countries, related to 17 proprietary scientificinventions(as of January Profile
TWST: How difficult is it to get a new therapy approved.

Dr. Burzynski: In the 1980's the average time to get approval of new medicine,

and to start making a profit was 22 years. Perhaps for